DK0935598T3 - 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet - Google Patents

5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet

Info

Publication number
DK0935598T3
DK0935598T3 DK97909992T DK97909992T DK0935598T3 DK 0935598 T3 DK0935598 T3 DK 0935598T3 DK 97909992 T DK97909992 T DK 97909992T DK 97909992 T DK97909992 T DK 97909992T DK 0935598 T3 DK0935598 T3 DK 0935598T3
Authority
DK
Denmark
Prior art keywords
oxopyrido
benzimidazole
heteroatom
substituted
alkyl
Prior art date
Application number
DK97909992T
Other languages
Danish (da)
English (en)
Inventor
Allen B Reitz
Alfonzo D Jordan
Malcolm K Scott
Pauline J Sanfilippo
Anna V Smith
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK0935598T3 publication Critical patent/DK0935598T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK97909992T 1996-10-07 1997-10-03 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet DK0935598T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2751196P 1996-10-07 1996-10-07

Publications (1)

Publication Number Publication Date
DK0935598T3 true DK0935598T3 (da) 2004-03-29

Family

ID=21838133

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97909992T DK0935598T3 (da) 1996-10-07 1997-10-03 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet

Country Status (13)

Country Link
US (1) US5817668A (fr)
EP (1) EP0935598B1 (fr)
JP (1) JP2001501949A (fr)
AR (1) AR013844A1 (fr)
AT (1) ATE256126T1 (fr)
AU (1) AU719333B2 (fr)
CA (1) CA2267943A1 (fr)
DE (1) DE69726749T2 (fr)
DK (1) DK0935598T3 (fr)
ES (1) ES2212081T3 (fr)
NZ (1) NZ335060A (fr)
PT (1) PT935598E (fr)
WO (1) WO1998015553A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922731A (en) * 1997-06-30 1999-07-13 Ortho Pharmaceutical Corporation 5- (heteroaryl)alkyl!-3-oxo-pyrido 1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
WO1999018105A1 (fr) * 1997-10-07 1999-04-15 Ortho-Mcneil Pharmaceutical, Inc. Derives de dipyrido-imidazole utiles pour le traitement de troubles du systeme nerveux central
ES2190112T3 (es) * 1997-10-07 2003-07-16 Ortho Mcneil Pharm Inc Derivados de naftoimidazo (1-2)piridina, su preparacion y su utilizacion para el tratamiento de trastornos del sistema nervioso central.
EP1107966B1 (fr) * 1998-08-25 2005-07-27 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: ligands du recepteur cerebral gaba
US6177569B1 (en) 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
US6358946B1 (en) 1999-08-02 2002-03-19 Ortho-Mcneil Pharmaceutical, Inc. C-6 ring-substituted pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders
GB0008696D0 (en) * 2000-04-07 2000-05-31 Merck Sharp & Dohme Therapeutic agents
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
AU2003298034B2 (en) * 2002-12-06 2011-04-21 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004532A1 (fr) * 1992-08-19 1994-03-03 Mcneilab, Inc. Derives de 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyle et de 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyle utiles dans le traitement de maladies du systeme nerveux central
US5521200A (en) * 1993-12-30 1996-05-28 Ho; Winston 2-oxo-pyrrolo[1,2-A]benzimidazole-3-carboxyl derivatives useful in treating central nervous system disorders

Also Published As

Publication number Publication date
AU719333B2 (en) 2000-05-04
ES2212081T3 (es) 2004-07-16
DE69726749D1 (de) 2004-01-22
EP0935598A1 (fr) 1999-08-18
PT935598E (pt) 2004-03-31
US5817668A (en) 1998-10-06
NZ335060A (en) 2000-05-26
EP0935598B1 (fr) 2003-12-10
AR013844A1 (es) 2001-01-31
ATE256126T1 (de) 2003-12-15
DE69726749T2 (de) 2005-07-21
WO1998015553A1 (fr) 1998-04-16
JP2001501949A (ja) 2001-02-13
AU4747397A (en) 1998-05-05
CA2267943A1 (fr) 1998-04-16

Similar Documents

Publication Publication Date Title
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
NO306977B1 (no) Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
AU4674797A (en) Phenylalaninol derivatives for the treatment of central nervous system disorders
DK0908458T3 (da) Substituerede pyridylmethylpiperazin- og piperidinderivater, deres fremstilling samt deres anvendelse til behandling af lidelser i centralnervesystemet (CNS)
DK1105390T3 (da) Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme
DK0983275T3 (da) Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
NO971512L (no) Nye pyrimido(1,2-a)indoler
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
BR9712030A (pt) Uso de benzopiranÄis para o tratamento de desordens neurolÄgicas
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
DK0964681T3 (da) Antikonvulsive derivater til behandling af psoriasis
UA25221A (uk) Спосіб лікуваhhя розладів цеhтральhої hервової системи
DK0783491T3 (da) Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid
ATE321044T1 (de) C-6 ringsubstituierte pyrido(1,2- a)benzimidazolderivate zur behandlung von störungen des zentralen nervensystems
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
DK0900078T3 (da) Anvendelse af benzonaphthalenderivater til fremstilling af lægemidler til behandling af sygdomme i nervesystemet